Delfa
AI-powered patient recruitment for clinical trials
London, United Kingdom · $3.8M raised
- Total Funding
- $3.8M
- Last Round
- $3.8M SeedAug 2025
- Rounds
- 1
About
Delfa is an AI-native operating system for clinical trials, focused on automating patient recruitment for clinical research sites. The platform deploys AI agents that conduct multilingual outreach via phone, SMS, and chat to prescreen patients for medical eligibility, answer questions, collect medical histories, schedule visits, and write directly into a site's CRM or CTMS. Founded by CEO Tom Farrand and CTO Gustav Bredell, Delfa raised a $3.8M seed round led by Air Street Capital and is live across 50+ trials, helping site networks like Flourish, Elevate, and Re:Cognition accelerate enrollment and reduce recruiter workload.
Summary
Delfa is an Artificial Intelligence company based in London, United Kingdom. It has raised $3.8M in total across 1 round, most recently a $3.8M Seed round in Aug 2025. Investors include Air Street Capital, Entrepreneur First and Transpose Platform Management.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2025
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.

xAI is an AI platform for accelerating human scientific discovery.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...

